Fisher & Paykel Healthcare Corporation Limited

Equities

FPH

NZFAPE0001S2

Medical Equipment, Supplies & Distribution

End-of-day quote New Zealand S.E. 07:00:00 2024-03-26 pm EDT 5-day change 1st Jan Change
26.42 NZD -0.11% Intraday chart for Fisher & Paykel Healthcare Corporation Limited +10.31% +11.95%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
New Zealand Shares Jump on Rate Cut Hopes; WasteCo Raises NZ$3 Million from Convertible Bond Offer MT
Fisher & Paykel Issues Limited Recall of Airvo Devices; Flags NZ$12 Million Hit MT
Fisher & Paykel Healthcare Expects NZ$1.73 FY Billion Operating Revenue MT
New Zealand Shares Jump on Friday, Fisher & Paykel Healthcare's Chair to Retire MT
Fisher & Paykel Healthcare's Chair to Retire MT
Fisher & Paykel Healthcare Corporation Limited Announces Board Changes CI
Morgan Stanley Adjusts Fisher & Paykel Healthcare’s Price Target to NZ$24.12 From NZ$23.12, Keeps at Equalweight MT
Morgan Stanley Adjusts Fisher & Paykel Healthcare’s Price Target to AU$22.19 From AU$21.50, Keeps at Equalweight MT
Australian shares gain as financials shine; market focus on inflation data RE
New Zealand shares snap 4-day rally but set for weekly gain; Australia closed RE
New Zealand Shares Rise on Strong Trading in Services Sector MT
Fisher & Paykel Healthcare Appoints COO MT
Fisher & Paykel Healthcare Corporation Limited Announces Board Changes CI
ResMed, Inc. continues to make headway in the sleep market Our Logo
Simon Barnard: A long-term vision at Smithson Our Logo
Fisher & Paykel Healthcare Corporation Limited Reports Earnings Results for the Half Year Ended September 30, 2023 CI
Australia shares extend gains as softer inflation lifts sentiment RE
Fisher & Paykel Lifts 1st Half Profit 12% Amid Easing Freight Costs DJ
Transcript : Fisher & Paykel Healthcare Corporation Limited, H1 2024 Earnings Call, Nov 29, 2023
Fisher & Paykel Healthcare Corporation Limited Approves Interim Dividend, Payable on 18 December 2023 CI
Fisher & Paykel Healthcare Launches Sleep Apnea Mask in New Zealand, Australia; Shares Up 2% MT
Fisher & Paykel Healthcare Corporation Limited Announces Launch of F&P Solo Mask in New Zealand and Australia for Treatment of Obstructive Sleep Apnea CI
Fisher & Paykel Healthcare Corporation Limited Announces Board Changes CI
Mercury NZ Elects Chairman MT
Fisher & Paykel Healthcare Sets Fiscal H1 Profit, Revenue Guidance MT
Chart Fisher & Paykel Healthcare Corporation Limited
More charts
Fisher & Paykel Healthcare Corporation Limited designs, manufactures and markets products and systems for use in acute and chronic respiratory care, surgery and the treatment of obstructive sleep apnea. The Company provides medical device products and systems for use in both hospital and homecare settings. Its hospital product group includes products used in invasive ventilation, noninvasive ventilation, nasal high flow therapy, anesthesia, and laparoscopic and open surgery. Its homecare product group includes devices and systems used to treat obstructive sleep apnea (OSA) and provide respiratory support in the home, which include its continuous positive airway pressure (CPAP) therapy masks as well as flow generators, interfaces, and data management technologies. The Company’s products are sold in over 120 countries worldwide. It operates across Canada, the United States of America, Mexico, Costa Rica, the United Kingdom, Switzerland, India and others.
Related indices
More about the company
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
14
Last Close Price
25.65 NZD
Average target price
23.63 NZD
Spread / Average Target
-7.89%
Consensus